PPARA and hypertriglyceridemia: In contrast, our current and previous work suggest that PPARα improves hepatic steatosis and hypertriglyceridemia by promoting increased channeling of fatty acids towards their oxidation and causing the induction of fatty acid oxidation genes; it also to some extent improves hepatic dyslipidemia by interfering with hepatic lipogenesis.